TR201010212A2 - Sefdinir içeren katı oral dozaj formu. - Google Patents
Sefdinir içeren katı oral dozaj formu.Info
- Publication number
- TR201010212A2 TR201010212A2 TR2010/10212A TR201010212A TR201010212A2 TR 201010212 A2 TR201010212 A2 TR 201010212A2 TR 2010/10212 A TR2010/10212 A TR 2010/10212A TR 201010212 A TR201010212 A TR 201010212A TR 201010212 A2 TR201010212 A2 TR 201010212A2
- Authority
- TR
- Turkey
- Prior art keywords
- dosage form
- oral dosage
- solid oral
- form containing
- containing cefdinir
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Mevcut buluş, aktif ajan olarak sefdinir içeren farmasötik bileşimlere ve bu bileşimlerin hazırlanmasında kullanılacak bir üretim yöntemine ilişkindir.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2010/10212A TR201010212A2 (tr) | 2010-12-08 | 2010-12-08 | Sefdinir içeren katı oral dozaj formu. |
PCT/TR2011/000273 WO2012078121A2 (en) | 2010-12-08 | 2011-12-02 | Solid oral dosage form comprising cefdinir |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2010/10212A TR201010212A2 (tr) | 2010-12-08 | 2010-12-08 | Sefdinir içeren katı oral dozaj formu. |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201010212A2 true TR201010212A2 (tr) | 2012-06-21 |
Family
ID=45491749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2010/10212A TR201010212A2 (tr) | 2010-12-08 | 2010-12-08 | Sefdinir içeren katı oral dozaj formu. |
Country Status (2)
Country | Link |
---|---|
TR (1) | TR201010212A2 (tr) |
WO (1) | WO2012078121A2 (tr) |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA836918B (en) | 1982-09-30 | 1984-05-30 | Fujisawa Pharmaceutical Co | 7-substituted-3-vinyl-3-cephem compounds and processes for the production of the same |
DK1166651T3 (da) * | 1996-02-29 | 2005-05-30 | Fujisawa Pharmaceutical Co | Hurtigt disintegrerende granulat af et syntetisk södemiddel indeholdende kiselsyre og/eller siliciumdioxid |
US20050131079A1 (en) * | 2003-12-10 | 2005-06-16 | Pujara Chetan P. | Cefdinir oral suspension |
US20050245738A1 (en) * | 2004-05-03 | 2005-11-03 | Lupin Ltd | Stable bioavailable crystalline form or cefdinir and a process for the preparation thereof |
JP2007077123A (ja) * | 2005-09-16 | 2007-03-29 | Shiono Chemical Co Ltd | 非晶質セフジニル、その製造方法およびこれを含有する経口投与用医薬組成物 |
CN101002745A (zh) * | 2005-09-26 | 2007-07-25 | 刘凤鸣 | 头孢地尼的缓释制剂 |
US20070128268A1 (en) * | 2005-12-07 | 2007-06-07 | Herwig Jennewein | Pharmaceutical compositions comprising an antibiotic |
WO2007086078A2 (en) * | 2006-01-30 | 2007-08-02 | Panacea Biotec Ltd. | Novel pharmaceutical compositions and process of preparation thereof |
US20090275552A1 (en) * | 2006-04-28 | 2009-11-05 | Mahesh Vithalbhai Patel | Therapy for Treating Resistant Bacterial Infections |
KR100990223B1 (ko) * | 2008-02-21 | 2010-10-29 | 주식회사 중외제약 | 세프디니르의 용출속도를 개선한 약제학적 조성물 |
CN101352424A (zh) * | 2008-09-16 | 2009-01-28 | 天津市中央药业有限公司 | 头孢地尼分散片及其制备方法 |
TR200909785A1 (tr) * | 2009-12-25 | 2011-07-21 | Bi̇lgi̇ç Mahmut | Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar. |
TR200909787A2 (tr) * | 2009-12-25 | 2011-07-21 | Bi̇lgi̇ç Mahmut | Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar. |
TR201001417A1 (tr) * | 2010-02-25 | 2011-09-21 | Sanovel İlaç San. Ve Ti̇c. A. Ş. | Geliştirilmiş çözünme hızına sahip sefdinir formülasyonu |
CN101862307A (zh) * | 2010-03-19 | 2010-10-20 | 杭州奥默医药技术有限公司 | 硫酸氢头孢地尼钠胶囊及其制备方法 |
WO2011139252A2 (en) * | 2010-05-04 | 2011-11-10 | Mahmut Bilgic | Efervescent formulations comprising cefdinir |
-
2010
- 2010-12-08 TR TR2010/10212A patent/TR201010212A2/tr unknown
-
2011
- 2011-12-02 WO PCT/TR2011/000273 patent/WO2012078121A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2012078121A3 (en) | 2012-08-23 |
WO2012078121A2 (en) | 2012-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201270741A1 (ru) | Пероральные композиции и липофильные соли метилналтрексона | |
SG194469A1 (en) | Tetrahydroquinoline derivatives useful as bromodomain inhibitors | |
MX348823B (es) | Formulaciones estables de linaclotida. | |
MX2019012939A (es) | Formulaciones que contienen linaclotida para administracion oral. | |
EA201590491A1 (ru) | Иммуногенная композиция | |
EA201291211A1 (ru) | Фармацевтические композиции, содержащие гидроморфон и налоксон | |
MX340983B (es) | Composiciones farmaceuticas y nutraceuticas de acido abscisico. | |
EA201201109A1 (ru) | Прасугрель в тонкоизмельченной кристаллической форме и фармацевтическая композиция, содержащая его | |
TR201906685T4 (tr) | Kristalin macitentan içeren farmasötik bileşim. | |
TR201009167A2 (tr) | Sefalosporin içeren farmasötik granüller. | |
MY163476A (en) | Oral care compositions | |
EA201390950A1 (ru) | Гомогенные фармацевтические пероральные лекарственные формы, содержащие лерканидипин и эналаприл или их фармацетически приемлемые соли совместно с органической кислотой | |
MX359887B (es) | Composicion masticable para administracion oral y proceso para preparar la misma. | |
TR200909785A1 (tr) | Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar. | |
PH12015501251A1 (en) | Compositions and methods for treating dental caries | |
EA201500313A1 (ru) | Стабилизированная аморфная форма агомелатина, способ ее изготовления и фармацевтические композиции, ее содержащие | |
TR201005327A2 (tr) | Sinerjik farmasötik formülasyonlar. | |
TR201010859A2 (tr) | Sefdinir içeren tablet formları. | |
TR200906506A2 (tr) | Telmisartan içeren katı dozaj formları. | |
TR201009166A2 (tr) | Sefdinir içeren farmasötik bileşim için üretim yöntemi | |
TR201010212A2 (tr) | Sefdinir içeren katı oral dozaj formu. | |
TR201100152A2 (tr) | Amlodipin içeren efervesan bileşimler. | |
TR201109160A2 (tr) | Eplerenon içeren yeni farmasötik kompozisyonlar. | |
TR201009165A2 (tr) | Sefdinir içeren tabletler | |
TR201009399A2 (tr) | Hızlı çözünen efervesan rosuvastatin formülasyonları. |